Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,336 GBX | +0.15% | +2.10% | +16.72% |
02:05pm | ASTRAZENECA : Buy rating from JP Morgan | ZD |
05-13 | AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.72% | 240B | |
+29.86% | 682B | |
+30.91% | 586B | |
-3.24% | 364B | |
+18.01% | 327B | |
+4.18% | 285B | |
+9.92% | 209B | |
-8.71% | 203B | |
+6.96% | 165B | |
-1.08% | 161B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Teams Up With Sernova to Develop Therapeutic Cell Technologies